Ray Dalio’s Signify Health, Inc. SGFY Stock Holding History

Ray Dalio’s Portfolio SGFY Stock Details SGFY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-77,040	Closed	-$2.21M	–	933
2022 Q4	$2.21M	Buy	77,040 +45,458	+144%	+$1.31M	0.01%	516
2022 Q3	$921K	Buy	+31,582	New	+$727K	﹤0.01%	711
2022 Q1	–	Sell	-24,788	Closed	-$352K	–	987
2021 Q4	$352K	Sell	24,788 -121,691	-83%	-$1.88M	﹤0.01%	679
2021 Q3	$2.62M	Buy	146,479 +18,799	+15%	+$483K	0.01%	394
2021 Q2	$3.88M	Buy	+127,680	New	+$3.51M	0.02%	375

Other funds holding SGFY

BHCM

Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Ray Dalio's SGFY Position: Q1 2023 in Review

Ray Dalio sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 77,040 shares — an estimated $2.21M sold.

Ray Dalio first reported a position in SGFY in Q2 2021 and held it in 5 quarters. The position peaked at $3.88M in Q2 2021. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

Ray Dalio reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
Ray Dalio sold 77,040 Signify Health, Inc. shares in Q1 2023, an estimated $2.21M.
Ray Dalio first reported a position in Signify Health, Inc. in Q2 2021 and held it in 5 quarters.
Ray Dalio's Signify Health, Inc. position peaked at $3.88M in Q2 2021.
5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on Bridgewater Associates's 13F filing for Q1 2023, filed 12 May 2023.